Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06576427 · ClinicalTrials.gov registry record · NA
Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II
A NA study of Pulmonary Embolism, sponsored by Jupiter Endovascular.
- Active
- Registry status
- NA
- Development phase
- 123
- Enrollment target
- 20
- Study locations
NCT06576427 is a NA study of Pulmonary Embolism that is active but no longer recruiting, run by Jupiter Endovascular. The registered enrollment target is 123 participants, below the 3,056-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (96% lower). The trial reports 20 study locations across 12 states.
The verdict
NCT06576427, a NA study of Pulmonary Embolism, is active but no longer recruiting, sponsored by Jupiter Endovascular.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 123 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is a prospective, single-arm, multicenter study to evaluate the safety and effectiveness of the Vertex Pulmonary Embolectomy System in participants presenting with clinical signs and symptoms of acute pulmonary embolism.
Conditions Studied
Interventions
- DEVICE Vertex Pulmonary Embolectomy System
Study Locations (20)
New York
- NYU Langone Health - New York
- Northwell Health - Staten Island
- Westchester Medical Center - Valhalla
North Carolina
- University of North Carolina - Chapel Hill
- Duke University - Durham
- Wake Forest Medical Center - Winston-Salem
Pennsylvania
- Penn Presbyterian - Philadelphia
- UPMC Presbyterian - Pittsburgh
- St Clair Health - Pittsburgh
Michigan
- Henry Ford Hospital - Detroit
- Henry Ford St John - Detroit
Other
- Medical University of Vienna - Vienna
- St. John Paul II Hospital - Krakow
Connecticut
- Hartford Hospital - Hartford
Florida
- Ascension Sacred Heart - Pensacola
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2024-10-15 |
| Est. Completion | 2026-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06576427
The ClinicalTrials.gov registry entry for NCT06576427 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,056-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (96% lower). The listed sponsor is Jupiter Endovascular, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Embolism appearing as the primary indexed condition, and to 1 intervention - of which Vertex Pulmonary Embolectomy System is the first listed.
NCT06576427 reports 20 study locations spanning 12 distinct geographic areas - top geographies include New York, North Carolina, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06576427 about?
NCT06576427 is a clinical study titled "Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II". This study is a prospective, single-arm, multicenter study to evaluate the safety and effectiveness of the Vertex Pulmonary Embolectomy System in participants presenting with clinical signs and symptoms of acute pulmonary embolism.
What is the current status of trial NCT06576427?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 123 participants. The study started on 2024-10-15. Estimated completion is 2026-03.
What conditions does trial NCT06576427 study?
This clinical trial studies the following conditions: Pulmonary Embolism.
What interventions are being tested in trial NCT06576427?
The interventions under investigation include: Vertex Pulmonary Embolectomy System (DEVICE).
Who is sponsoring clinical trial NCT06576427?
This trial is sponsored by Jupiter Endovascular, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06576427 being conducted?
This trial has 20 study locations across Connecticut, Florida, Georgia, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PERSEVERE Study
RECRUITING · NA
-
The PEERLESS II Study
RECRUITING · NA
-
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.